Gene-silencing technology gets first drug approval after 20-year wait

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/d41586-018-05867-7PMID 30108348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

  2018cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper

• C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer’s Disease

  2025cites this paper
• From nematode to Nobel: How community-shared resources fueled the rise of Caenorhabditis elegans as a research organism

  2025cites this paper
• Next-generation nanocarriers for therapeutic oligonucleotides: Precision targeting and stimuli-responsive cancer therapy.

  2025cites this paper
• Non-Coding RNAs in Asthma: Regulators of Eosinophil Biology and Airway Inflammation

  2025cites this paper
• Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy

  2025cites this paper
• Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver disease.

  2025cites this paper
• Effect of the size of nucleic acid delivery systems on their fate in cancer treatment

  2024cites this paper
• Unlocking the Potential of RNA Nanoparticles: A Breakthrough Approach to Overcoming Challenges in Colon Cancer Treatment.

  2024cites this paper
• Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery

  2024cites this paper
• Stability and conformation of DNA-hairpin in cylindrical confinement.

  2024cites this paper
• SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers

  2024cites this paper
• Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics/physiologically-based pharmacokinetic approaches

  2024cites this paper
• Similarities and Differences in Ligand Binding to Protein and RNA Targets: The Case of Riboflavin

  2024cites this paper
• Advancements in clinical RNA therapeutics: Present developments and prospective outlooks

  2024cites this paper
• The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors

  2023cites this paper
• Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development

  2023cites this paper
• siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway.

  2023cites this paper
• RNA nanomedicine in liver diseases

  2023cites this paper
• Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers

  2023cites this paper
• A Straightforward Method for the Development of Positively Charged Gold Nanoparticle-Based Vectors for Effective siRNA Delivery

  2023cites this paper
• Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy

  2023cites this paper
• A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23.

  2023cites this paper
• Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme

  2023cites this paper
• Preclinical Safety Assessment of Therapeutic Oligonucleotides.

  2022cites this paper
• Pathological changes in GPCR signal organisation: Opportunities for targeted therapies for triple negative breast cancer.

  2022cites this paper
• Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D TARDBP mutation

  2022cites this paper
• Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer

  2022cites this paper
• A Triazolium‐Anchored Self‐Immolative Linker Enables Self‐Assembly‐Driven siRNA Binding and Esterase‐Induced Release

  2022cites this paper
• CRISPR/Cas9 in the era of nanomedicine and synthetic biology.

  2022cites this paper
• Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection

  2022cites this paper
• Targeting a broad spectrum of KRAS-mutant cancers by hyperactivation-induced cell death

  2022cites this paper
• Meeting report: oligonucleotide ADME workshop

  2022cites this paper
• Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy.

  2022cites this paper
• A biodegradable amphiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery.

  2022cites this paper
• Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks

  2022influential citation
• Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)

  2022cites this paper
• miR-204-5p in vivo inhibition cause diminished CD45RO cells rate in lungs of melanoma B16-bearing mice

  2022cites this paper
• RNAi-based modulation of IFN-γ signaling in skin

  2022cites this paper
• A dynamic DNA nanosponge for triggered amplification of gene-photodynamic modulation

  2022cites this paper
• RIG-I-Mediated Innate Immune Stimulation by Chemically Synthesized Long Double-Stranded RNAs Is Structure and Sequence Dependent

  2022cites this paper
• Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment

  2022cites this paper
• Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy

  2021cites this paper
• Long and short non-coding RNA and radiation response: a review.

  2021cites this paper
• Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles.

  2021cites this paper
• Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A

  2021cites this paper
• Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS

  2021cites this paper
• Lipid based Nanocarriers for effective Drug Delivery and Treatment of Diabetes Associated Liver Fibrosis.

  2021cites this paper
• A comparative analysis of international health technology assessments for novel gene silencing therapies: patisiran and inotersen

  2021cites this paper
• Cell penetration peptide-based nanomaterials in drug delivery and biomedical applications

  2021cites this paper
• RNA interference and CRISPR/Cas9 techniques for controlling mycotoxins

  2021cites this paper
• Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance

  2021cites this paper
• Conformation Sensitive Targeting of Lipid Nanoparticles for RNA Therapeutics

  2021cites this paper
• Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease

  2021cites this paper
• The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells

  2021cites this paper
• The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer

  2021cites this paper
• Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs

  2021cites this paper
• Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation

  2021cites this paper
• Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics.

  2021cites this paper
• Mechanisms of Fibrosis Development in NASH.

  2020cites this paper
• Directed arrangement of siRNA via polymerization-induced electrostatic self-assembly.

  2020cites this paper
• Branched Antisense and siRNA Co‐Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy

  2020cites this paper
• Amphiphilic peptide dendrimer-based nanovehicles for safe and effective siRNA delivery

  2020cites this paper
• Frameworks for targeting RNA with small molecules

  2020cites this paper
• Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Anti-Fibrotic and Anti-Inflammatory Activities.

  2020cites this paper
• Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient siRNA Delivery

  2020cites this paper
• Experimentally Validated QSAR Model for Surface pKa Prediction of Heterolipids Having Potential as Delivery Materials for Nucleic Acid Therapeutics

  2020cites this paper
• Epigenetic regulation of the anterior segment diseases and potential therapeutics.

  2020cites this paper
• RNAi drugs: Next generation drugs?

  2020cites this paper
• On the Binding Dynamics of siRNA with selected Lipopeptides: A Computer-Aided Study of the Effect of Lipopeptides' Functional Groups and Stereoisomerism.

  2020cites this paper
• miR-211-5p alleviates focal cerebral ischemia-reperfusion injury in rats by down-regulating the expression of COX2.

  2020cites this paper
• Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy.

  2020cites this paper
• Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs.

  2020cites this paper
• An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile

  2020cites this paper
• miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

  2020cites this paper
• Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles

  2020cites this paper
• Simulating gene silencing through intervention analysis

  2020cites this paper
• Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome

  2020cites this paper
• Emerging Contribution of PancRNAs in Cancer

  2020cites this paper
• Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

  2020cites this paper
• Inhaled RNA Therapy: From Promise to Reality

  2020cites this paper
• Paving the Road for RNA Therapeutics

  2020cites this paper
• Branched Antisense and siRNA Co-assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy.

  2020cites this paper
• RNA-based pharmacotherapy for tumors: From bench to clinic and back.

  2020cites this paper
• Tracking nucleic acid nanocapsule assembly, cellular uptake and disassembly using a novel fluorescently labeled surfactant

  2020cites this paper
• A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice

  2019cites this paper
• The development of tertiary amine cationic lipids for safe and efficient siRNA delivery.

  2019cites this paper
• Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.

  2019cites this paper
• Disruptive Technology: CRISPR/Cas-Based Tools and Approaches

  2019cites this paper
• Developing small activating RNA as a therapeutic: current challenges and promises.

  2019cites this paper
• Risk factors for communicable diseases in humanitarian emergencies and disasters: Results from a three-stage expert elicitation

  2019cites this paper
• Foxp3 plasmid-encapsulated PLGA nanoparticles attenuate pain behavior in rats with spinal nerve ligation.

  2019cites this paper
• Specificity from nonspecific interaction: regulation of tumor necrosis factor-α activity by DNA

  2019cites this paper
• "Mining the Epitranscriptome: Detection of RNA editing and RNA modifications".

  2019cites this paper
• miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC.

  2019cites this paper
• A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia

  2019cites this paper
• Specificity from non-specific interaction: regulation of TNF-  activity by DNA

  2019cites this paper
• The approved gene therapy drugs worldwide: from 1998 to 2019.

  2019cites this paper
• A brief comparison between experimental and computationally-generated ensembles of RNA dinucleotides.

  2019cites this paper
• Naked pDNA/Hyaluronic Acid Powder Shows Excellent Long-term Storage Stability and Gene Expression in Murine Lungs.

  2019cites this paper